{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:25:18Z","timestamp":1793291118774,"version":"4.5.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 has exacerbated income inequality, structural racism, and social isolation\u2014issues that drive addiction and have previously manifested in the epidemic of opioid-associated overdose. The co-existence of these epidemics has necessitated care practice changes, including the use of telehealth-based encounters for the diagnosis and management of opioid use disorder (OUD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We describe the development of the \u201cAddiction Telehealth Program\u201d (ATP), a telephone-based program to reduce treatment access barriers for people with substance use disorders staying at San Francisco's COVID-19 Isolation and Quarantine (I&amp;Q) sites. Telehealth encounters were documented in the electronic medical record and an internal tracking system for the San Francisco Department of Public Health (SFDPH) COVID-19 Containment Response. Descriptive statistics were collected on a case series of patients initiated on buprenorphine at I&amp;Q sites and indicators of feasibility were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between April 10 and May 25, 2020, ATP consulted on the management of opioid, alcohol, GHB, marijuana, and stimulant use for 59 I&amp;Q site guests. Twelve patients were identified with untreated OUD and newly prescribed buprenorphine. Of these, all were marginally housed, 67% were Black, and 58% had never previously been prescribed medications for OUD. Four self-directed early discharge from I&amp;Q\u20141 prior to and 3 after initiating buprenorphine. Of the remaining 8 patients, 7 reported continuing to take buprenorphine at the time of I&amp;Q discharge and 1 discontinued. No patients started on buprenorphine sustained significant adverse effects, required emergency care, or experienced overdose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ATP demonstrates the feasibility of telephone-based management of OUD among a highly marginalized patient population in San Francisco and supports the implementation of similar programs in areas of the U.S. where access to addiction treatment is limited. Legal changes permitting the prescribing of buprenorphine via telehealth without the requirement of an in-person visit should persist beyond the COVID-19 public health emergency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2021.1890676","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T17:02:55Z","timestamp":1615222975000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":41,"title":["Covid-19: A Catalyst for Change in Telehealth Service Delivery for Opioid Use Disorder Management"],"prefix":"10.1177","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-6889","authenticated-orcid":false,"given":"Nicky J.","family":"Mehtani","sequence":"first","affiliation":[{"name":"Division of HIV, ID &amp; Global Medicine, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6308-6604","authenticated-orcid":false,"given":"Jessica T.","family":"Ristau","sequence":"additional","affiliation":[{"name":"Division of HIV, ID &amp; Global Medicine, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Snyder","sequence":"additional","affiliation":[{"name":"Department of Family &amp; Community Medicine, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Surlyn","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Eveland","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0701-8361","authenticated-orcid":false,"given":"Shannon","family":"Smith-Bernardin","sequence":"additional","affiliation":[{"name":"School of Nursing, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-8592","authenticated-orcid":false,"given":"Kelly R.","family":"Knight","sequence":"additional","affiliation":[{"name":"Department of Anthropology, History, and Social Medicine, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/12054.001.0001"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303483"},{"key":"e_1_3_2_5_1","unstructured":"Substance Abuse and Mental Health Substance Administration. 2020. Double Jeopardy: COVID-19 and behavioral health disparities for Black and Latino communities in the U.S. Washington DC. https:\/\/www.samhsa.gov\/sites\/default\/files\/covid19-behavioral-health-disparities-black-latino-communities.pdf. Accessed May 18 2020."},{"issue":"3","key":"e_1_3_2_6_1","article-title":"Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic","volume":"1","author":"Nouri S","year":"2020","unstructured":"Nouri S, , Khoong EC, , Lyles CR, , Karliner L. Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic. NEJM Catalyst Innovations in Care Delivery. 2020;1(3). https:\/\/catalyst.nejm.org\/doi\/pdf\/10.1056\/CAT.20.0123","journal-title":"NEJM Catalyst Innovations in Care Delivery"},{"key":"e_1_3_2_7_1","unstructured":"John Hopkins University. COVID-19 map-Johns Hopkins Coronavirus Resource Center; 2020. https:\/\/coronavirus.jhu.edu\/covid-19-daily-video."},{"key":"e_1_3_2_8_1","unstructured":"San Francisco Department of Public Health. Tracking COVID-19 in San Francisco. https:\/\/data.sfgov.org\/stories\/s\/dak2-gvuj."},{"key":"e_1_3_2_9_1","unstructured":"Thadani T. If COVID-19 isn't driving a dramatic increase in homeless deaths in SF then what is? San Francisco Chronicle. August 19 2020. https:\/\/www.sfchronicle.com\/politics\/article\/If-COVID-19-isn-t-driving-a-dramatic-increase-15493665.php."},{"key":"e_1_3_2_10_1","unstructured":"Thadani T. More than one person a day died in SF of an overdose last year. This year is expected to be worse. San Francisco Chronicle. August 31 2020. https:\/\/www.sfchronicle.com\/politics\/article\/More-than-one-person-a-day-died-in-SF-of-an-15529006.php."},{"key":"e_1_3_2_11_1","unstructured":"American Society of Addiction Medicine. Caring for patients during the COVID-19 pandemic: ASAM COVID-19 Task Force recommendations. https:\/\/www.asam.org\/docs\/default-source\/covid-19\/drug-testing-guidance_042820.pdf?sfvrsn=ff854c2_2. Accessed May 18 2020."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30460-8"},{"key":"e_1_3_2_13_1","unstructured":"National Health Care for the Homeless Council. Reducing harm for people using drugs & alcohol during the COVID-19 pandemic: a guide for alternate care sites programs [Internet]. National Health Care for the Homeless Council; 2020 April. https:\/\/nhchc.org\/wp-content\/uploads\/2020\/04\/Reducing-Harm-During-COVID-19-for-People-Using-Drugs-at-ACS1.pdf. Accessed May 10 2020."},{"key":"e_1_3_2_14_1","unstructured":"Substance Abuse and Mental Health Substance Administration. FAQs: provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency. Washington DC. https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf. Accessed May 10 2020."},{"key":"e_1_3_2_15_1","unstructured":"Brico E. 2020. The pandemic is restricting health options for people who use drugs; 2020. Filter Magazine. https:\/\/filtermag.org\/coronavirus-health-drugs\/. Accessed May 10 2020."},{"key":"e_1_3_2_16_1","unstructured":"American Society of Addiction Medicine. Caring for Patients During the COVID-19 Pandemic: ASAM COVID-19 Task Force Recommendations; 2020. https:\/\/www.asam.org\/docs\/default-source\/covid-19\/drug-testing-guidance_042820.pdf?sfvrsn=ff854c2_2. Accessed May 18 2020."},{"key":"e_1_3_2_17_1","unstructured":"Substance Abuse and Mental Health Substance Administration. Considerations for the care and treatment of mental and susbtance use disorders in the COVID-19 epidemic; 2020. https:\/\/www.samhsa.gov\/sites\/default\/files\/considerations-care-treatment-mental-substance-use-disorders-covid19.pdf. Accessed May 18 2020."},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05125"},{"key":"e_1_3_2_19_1","unstructured":"San Francisco Department of Public Health. 2020. Order of the health officer No.C19-07b. https:\/\/www.sfdph.org\/dph\/alerts\/files\/HealthOfficerOrder-C19-07b-ShelterInPlace-03312020.pdf."},{"key":"e_1_3_2_20_1","unstructured":"California Department of Public Health. COVID-19 updates. Getting health care from home through Telehealth; 2020. https:\/\/covid19.ca.gov\/telehealth\/. Accessed May 18 2020."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2013.06.032"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/virtualmentor.2014.16.9.spec1-1409"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.10.020"},{"key":"e_1_3_2_24_1","unstructured":"Thadani T. San Francisco homeless deaths soar \u2013 and officials say it's not directly due to COVID-19. San Francisco Chronicle. May 26 2020. https:\/\/www.sfchronicle.com\/politics\/article\/San-Francisco-homeless-deaths-soar-and-it-s-15295730.php."},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-015-0035-4"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12805"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.03.007"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.02.011"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05134"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900444"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3932643"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1752351"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1890676","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.1890676","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1890676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:28:27Z","timestamp":1780507707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.1890676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1080\/08897077.2021.1890676"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.1890676","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}